Mir-320e and colorectal cancer

作者: C. Richard Boland , Lucia Perez-Carbonell , Ajay Goel

DOI:

关键词:

摘要: Embodiments provide methods and compositions related to determining treatments for colorectal cancer patients by detection analysis of the expression level miRNA such as miR-320e in patients. predictive, prognostic and/or diagnostics identifying miRNAs that are useful clinical management patients, particularly or at risk determined have cancer. Methods based, part, on discovery certain is associated with advancing stages can predict responsiveness therapy, can, therefore, basis designing treatment strategies. In particular embodiments, molecule miR-320, miR-320e.

参考文章(42)
Christian Langer, Michael D Radmacher, Amy S Ruppert, Susan P Whitman, Peter Paschka, Krzysztof Mrózek, Claudia D Baldus, Tamara Vukosavljevic, Chang-Gong Liu, Mary E Ross, Bayard L Powell, Albert De La Chapelle, Jonathan E Kolitz, Richard A Larson, Guido Marcucci, Clara D Bloomfield, None, High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study Blood. ,vol. 111, pp. 5371- 5379 ,(2008) , 10.1182/BLOOD-2007-11-124958
Lucía Pérez-Carbonell, Frank A. Sinicrope, Steven R. Alberts, Ann L. Oberg, Francesc Balaguer, Antoni Castells, C. Richard Boland, Ajay Goel, 110 MiR-320e Is a Prognostic and Predictive Biomarker in Colorectal Cancer Gastroenterology. ,vol. 146, pp. S- 30 ,(2014) , 10.1016/S0016-5085(14)60105-0
Rafael G. Amado, Michael Wolf, Marc Peeters, Eric Van Cutsem, Salvatore Siena, Daniel J. Freeman, Todd Juan, Robert Sikorski, Sid Suggs, Robert Radinsky, Scott D. Patterson, David D. Chang, Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer Journal of Clinical Oncology. ,vol. 26, pp. 1626- 1634 ,(2008) , 10.1200/JCO.2007.14.7116
Michael Klass, George Poste, Christine Kuslich, Methods and systems of using exosomes for determining phenotypes ,(2009)
Troels Schepeler, Jørgen T. Reinert, Marie S. Ostenfeld, Lise L. Christensen, Asli N. Silahtaroglu, Lars Dyrskjøt, Carsten Wiuf, Frank J. Sørensen, Mogens Kruhøffer, Søren Laurberg, Sakari Kauppinen, Torben F. Ørntoft, Claus L. Andersen, Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer Cancer Research. ,vol. 68, pp. 6416- 6424 ,(2008) , 10.1158/0008-5472.CAN-07-6110
S.-z. Jia, Y. Yang, J. Lang, P. Sun, J. Leng, Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women with endometriosis Human Reproduction. ,vol. 28, pp. 322- 330 ,(2013) , 10.1093/HUMREP/DES413
Keun Hur, Yuji Toiyama, Clement R. Boland, Ajay Goel, Su1880 Identification of a Novel Metastasis-Specific miRNA Signature in Human Colorectal Cancer Gastroenterology. ,vol. 142, pp. S- 525 ,(2012) , 10.1016/S0016-5085(12)62019-8
M Kalimutho, S Di Cecilia, G Del Vecchio Blanco, F Roviello, P Sileri, M Cretella, A Formosa, G Corso, D Marrelli, F Pallone, G Federici, S Bernardini, Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer. British Journal of Cancer. ,vol. 104, pp. 1770- 1778 ,(2011) , 10.1038/BJC.2011.82
Wen Pan, Shu Zhu, Min Yuan, Huijuan Cui, Lijia Wang, Xiaobing Luo, Jia Li, Haibo Zhou, Yuanjia Tang, Nan Shen, MicroRNA-21 and MicroRNA-148a Contribute to DNA Hypomethylation in Lupus CD4+ T Cells by Directly and Indirectly Targeting DNA Methyltransferase 1 Journal of Immunology. ,vol. 184, pp. 6773- 6781 ,(2010) , 10.4049/JIMMUNOL.0904060
Christine M. Ribic, Daniel J. Sargent, Malcolm J. Moore, Stephen N. Thibodeau, Amy J. French, Richard M. Goldberg, Stanley R. Hamilton, Pierre Laurent-Puig, Robert Gryfe, Lois E. Shepherd, Dongsheng Tu, Mark Redston, Steven Gallinger, Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer The New England Journal of Medicine. ,vol. 349, pp. 247- 257 ,(2003) , 10.1056/NEJMOA022289